Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises FSN Capital in connection with the acquisition of Seriline
Mandate

Vinge advises FSN Capital in connection with the acquisition of Seriline

February 23, 2022 Intellectual Property M&A Corporate Crime & Compliance Employment and Benefits Banking and Finance IT, Telecommunications and Outsourcing Commercial Agreements

Vinge advises FSN Capital in connection with the acquisition of a majority stake in Seriline AB from its current shareholders, who will retain a sizable stake in the company.

Serline was founded in 1990 and is a provider of Identity and Access Management (IAM) solutions. Seriline offers proprietary software, online solutions, hardware and services that simplify the flow to creating user-friendly processes for confidentiality and integrity management of identities. Seriline has 29 FTEs and had SEK 84m in sales in 2021. The company is expected to be the initial platform in FSN’s buy-and-build strategy to create a Nordic cybersecurity leader within IAM.

Established in 1999, FSN Capital Partners is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds, with €4 billion under management. FSN Capital Funds make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities. 

Vinge’s team mainly consisted of Johan Winnerblad, Maria Dahlin Kolvik, Eléonore Friberg and Ebba Nyberg (M&A), Mathilda Persson and Karolina Fuhrman (IT/GDPR), Martin Boström (Commercial agreements), Felix Möller (Bank and Finance), Gustav Lindgren (Arbetsrätt), Sofia Bergenstråhle och Axel Lennartsson (IP), Tove Lövgren Frisk (Compliance), Ellinor Gyllenhammar and Elin Kollin (VDR).

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026